Craft
  • Home
  •  / Shockwave Medical
Shockwave Medical

Shockwave Medical

Patients Tested to Date

179

Feb, 2019

Revenue

$237.1 M

FY, 2021

Market Capitalization

$6.2 B

2023-01-19

Shockwave Medical Summary

Company summary

Overview
Shockwave Medical is a company developing interventional therapy for calcified cardiovascular disease. It provides the Lithoplasty balloon dilatation catheters. The company also offers intravascular lithotripsy, a novel treatment option that allows calcium modification.
Type
Public
Status
Active
Founded
2009
HQ
Santa Clara, CA, US | view all locations
Website
http://shockwavemedical.com/
Cybersecurity rating
ESG rating
40-49 out of 100|View all ESG data
Sectors

Key people

  • Doug Godshall

    Doug Godshall, President and CEO

  • Isaac Zacharias

    Isaac Zacharias, President & Chief Commercial Officer

  • Dan Puckett
  • Beaux Alexander

    Beaux Alexander, VP of Clinical Affairs

Operating MetricsView all

Patients Tested to Date

179

Feb, 2019

LocationsView all

2 locations detected

  • Santa Clara, CA HQ

    United States

    5403 Betsy Ross Dr

  • Kleve, NRW

    Germany

    Siemensstraße 31

Shockwave Medical Financials

Summary financials

Revenue (Q3, 2022)
$131.3M
Gross profit (Q3, 2022)
$113.5M
Net income (Q3, 2022)
$35.0M
Cash (Q3, 2022)
$127.8M
EBIT (Q3, 2022)
$36.8M
Enterprise value
$6.1B

Footer menu